Key findings

  • 27.9%of 215 adolescents aged 10–18 years reported severe respiratory symptoms
  • r = 0.87correlation between PM2.5 concentration and respiratory symptom prevalence in 120 adults aged 55 years and older (p < 0.01)
  • 25–35%lower respiratory symptom prevalence associated with regular mask use among the older adults
  • 258.1 and 13.8estimated additional outpatient visits and inpatient admissions per week associated with each 10 µg/m³ increase in PM2.5, in aggregated hospital data

Abstract

Background
Fine particulate matter with an aerodynamic diameter of 2.5 micrometers or less is an important environmental health concern in Bangkok and surrounding areas. Adolescents and older adults may experience different patterns of susceptibility, while periods of elevated air pollution may also coincide with increased demand for healthcare services. This study integrated complementary datasets to examine respiratory health outcomes and healthcare utilization in these populations.
Methods
An integrated secondary analysis was conducted using three complementary data sources: an adolescent health dataset, an epidemiological study of adults aged 55 years and older, and aggregated healthcare-utilization records from Bangkok and surrounding areas. Each dataset was analyzed independently according to its original study design; individual participants were not linked or pooled across datasets. Respiratory symptoms, particulate-matter exposure, protective behaviors, outdoor exposure, and outpatient and inpatient healthcare utilization were examined. Findings across the datasets were subsequently compared descriptively to identify convergent patterns of respiratory health burden and healthcare demand.
Results
Respiratory symptoms were observed in both younger and older populations. Among adolescents, 27.9% reported severe respiratory symptoms, while 33.5% demonstrated low awareness of fine particulate matter. Among adults aged 55 years and older, particulate-matter concentration was positively associated with respiratory symptom prevalence (r = 0.87, p < 0.01). Shortness of breath (70.8%), persistent cough (60.0%), and chest tightness (54.2%) were among the most frequently reported symptoms. Regular mask use was associated with approximately 25–35% lower symptom prevalence, whereas high outdoor exposure was associated with a greater symptom burden. At the healthcare-system level, particulate-matter concentration was positively associated with both outpatient (r = 0.758) and inpatient (r = 0.691) utilization. In the supplementary healthcare dataset, adults aged over 60 years accounted for 58.6% of outpatient visits and 62.2% of recorded inpatient admissions.
Conclusion
Complementary datasets from Bangkok and surrounding areas indicate that fine particulate matter exposure is associated with respiratory health burden in adolescents and older adults and with increased healthcare utilization. The findings support age-responsive public health measures, including improved air-quality awareness, reduction of unnecessary outdoor exposure during high-pollution periods, appropriate respiratory protection, and healthcare preparedness. Because the datasets differed in design and were not linked at the individual level, the integrated findings should be interpreted as convergent observational evidence rather than as evidence of a single causal pathway.

Introduction

Fine particulate matter with an aerodynamic diameter of 2.5 micrometers or less is an important environmental and public health concern because its small particle size allows it to penetrate deeply into the respiratory tract. Exposure has been associated with respiratory symptoms, impaired pulmonary function, exacerbation of asthma and other respiratory diseases, and increased use of healthcare services. Children, adolescents, older adults, and individuals with pre-existing respiratory conditions may be particularly susceptible to adverse effects because of differences in physiological vulnerability, activity patterns, underlying disease, and cumulative environmental exposure.

Bangkok and its surrounding provinces experience recurrent episodes of elevated fine particulate matter, particularly during periods characterized by unfavorable atmospheric conditions and emissions from traffic, combustion, industry, and other urban sources. These episodes create an important public health challenge because large populations may be exposed simultaneously. The health consequences of such exposure may therefore be reflected not only in symptoms experienced by individuals but also in increased demand for outpatient and inpatient healthcare.

Respiratory health in children and adolescents

Children and adolescents represent an important population for air-pollution research because respiratory development continues throughout childhood and adolescence. Their activity patterns may also increase exposure, particularly through outdoor school activities, commuting, and exercise. Previous epidemiological evidence has linked particulate-matter exposure with respiratory symptoms and impaired lung development in younger populations.

Evidence from Bangkok and Nonthaburi further suggests that respiratory symptoms are relevant among Thai school-aged populations exposed to fine particulate matter. Previous local studies have examined respiratory complaints, awareness of air pollution, protective behavior, and daily exposure among students. These findings highlight the importance of considering not only environmental concentrations but also behavioral factors that may influence actual exposure.

Adolescence is also a period during which individuals increasingly make independent decisions regarding outdoor activities and personal protective behavior. Awareness of air-quality information and appropriate responses to high-pollution episodes may therefore represent potentially modifiable factors. Examining respiratory symptoms together with awareness and exposure-related behavior can provide information relevant to school-based environmental health interventions.

Respiratory health in older adults

Older adults constitute another population of concern. Age-related physiological changes, accumulated exposure, and a greater prevalence of chronic respiratory conditions may increase susceptibility to air pollution. In the Bangkok older-adult dataset included in the present integrated analysis, higher fine-particulate-matter concentrations were associated with greater respiratory symptom prevalence. Shortness of breath, persistent cough, chest tightness, and wheezing were among the reported outcomes.

Behavior may modify this relationship. In the same study, regular mask use was associated with approximately 25–35% lower symptom prevalence, whereas participants with high outdoor exposure experienced substantially greater symptom burden. These observations suggest that ambient concentration alone may not fully represent individual exposure and that behavioral characteristics should be considered when interpreting pollution-related health effects.

The present study focuses primarily on respiratory outcomes. Cardiovascular observations recorded in the older-adult source dataset are treated as secondary contextual findings rather than primary outcomes. This distinction was made to maintain a focused research question and to avoid inferring direct cardiovascular effects from short-term observational associations.

Fine particulate matter and healthcare utilization

The public health consequences of air pollution extend beyond symptoms at the individual level. Increased respiratory morbidity during pollution episodes can potentially translate into greater demand for clinical services. Accordingly, healthcare-utilization data provide a complementary system-level perspective on the burden associated with fine particulate matter.

Previous healthcare analysis from Bangkok and neighboring provinces reported a mean fine-particulate-matter concentration of 45.7 µg/m3 (SD = 12.3) during January–February 2025, with concentrations exceeding 70 µg/m3 during high-pollution periods. Positive correlations were reported between particulate-matter concentrations and outpatient utilization (r = 0.758) and inpatient utilization (r = 0.691).

The same study estimated increases in outpatient and inpatient utilization with increasing particulate-matter concentration. These associations suggest that environmental air pollution may have implications for healthcare-resource planning. However, hospital utilization is influenced by many factors, including underlying disease prevalence, infectious-disease activity, population structure, healthcare access, and healthcare-seeking behavior. Consequently, aggregated healthcare data should not be interpreted as demonstrating that a particular pollution exposure caused an individual hospital visit.

Rationale for an integrated analysis

Most individual studies examine one population or one level of health burden at a time. A study of school students may characterize respiratory symptoms and protective behavior, whereas a study of older adults may evaluate symptom patterns in a potentially more vulnerable population. Hospital records, in contrast, describe healthcare demand but generally cannot provide the same individual-level behavioral information.

Integrating these sources can provide a broader perspective, but such integration requires methodological caution. In the present study, the component datasets represent complementary but distinct populations and levels of observation. They were not matched at the participant level, and the presence of respiratory symptoms in one dataset was not paired statistically with healthcare utilization in another dataset.

Accordingly, this study does not construct a single combined cohort and does not assume that two common health conditions observed in separate or aggregated datasets are directly associated with each other. Instead, each dataset is analyzed within its original structure, and the findings are subsequently considered together to determine whether they show convergent patterns of respiratory health burden and healthcare utilization in relation to fine particulate matter exposure.

This approach is particularly relevant for Bangkok and surrounding areas, where younger populations, older adults, and healthcare systems may experience different dimensions of the same air-pollution problem. Importantly, the geographical scope of the component datasets is limited primarily to Bangkok, Nonthaburi, and surrounding provinces; therefore, the findings are not intended to represent nationally representative estimates for the entire Thai population.

Study objectives

The primary objective of this study was to integrate complementary observational evidence to examine fine-particulate-matter exposure in relation to respiratory health among adolescents and older adults and healthcare utilization in Bangkok and surrounding areas.

Specifically, the study aimed to: (1) characterize respiratory symptoms and relevant exposure-related behaviors among adolescents; (2) examine the relationship between fine-particulate-matter exposure and respiratory symptoms among adults aged 55 years and older; (3) examine whether mask use and outdoor exposure were associated with differences in respiratory symptom burden; and (4) describe the relationship between fine-particulate-matter concentrations and outpatient and inpatient healthcare utilization.

The datasets were analyzed independently rather than pooled at the individual level. Therefore, the integrated analysis was designed to identify complementary and convergent patterns across datasets, rather than to establish causal relationships between individual respiratory symptoms and subsequent healthcare utilization.

Materials and Methods

Study design

This study used an integrated secondary-analysis design to examine the relationship between fine particulate matter exposure, respiratory health, and healthcare utilization in Bangkok and surrounding areas. The analysis incorporated complementary datasets representing adolescent health, older-adult health, and healthcare utilization.

The component datasets were analyzed independently according to their original study structures. Individual participants were not linked across datasets, and the datasets were not pooled to create a single cohort. Integration was performed at the interpretation stage to identify convergent patterns across different populations and levels of observation. Therefore, associations identified within one dataset were not assumed to represent individual-level relationships with outcomes recorded in another dataset.

Data sources and study populations

Three complementary data streams were included. Adolescent health data. The adolescent component included school-aged participants from Bangkok and surrounding areas. Available data included respiratory symptoms, awareness of fine particulate matter, exposure-related behavior, mask use, outdoor activity, and healthcare-related outcomes. Analyses were conducted within the adolescent dataset only. Where the original source did not provide sufficiently detailed temporal information, no attempt was made to reconstruct or infer individual exposure dates.

Older-adult health data. The older-adult component comprised 120 adults aged 55 years and older in Bangkok who were observed during January–February 2025. Fine-particulate-matter exposure was evaluated in relation to respiratory symptoms and exposure-related behaviors. The original study assessed shortness of breath, persistent cough, wheezing, chest tightness, and eye irritation, together with mask use and time spent outdoors.

Healthcare-utilization data. The healthcare component consisted of aggregated outpatient and inpatient records from Bangkok and neighboring provinces during January–February 2025. The original healthcare analysis included Bangkok, Samut Prakan, Pathum Thani, and Nonthaburi and linked temporally aggregated healthcare utilization with ambient fine-particulate-matter monitoring data.

An additional healthcare dataset covering 1 January–21 February 2025 was used to describe utilization according to age group and clinical department. Because this dataset may overlap with records represented in the previously analyzed healthcare-utilization dataset, it was treated as supplementary descriptive data rather than an independent cohort. Counts from these two healthcare sources were not added together.

Table 1. Characteristics of the Data Sources Included in the Integrated Analysis

CharacteristicAdolescentsOlder AdultsHealthcare Utilization
Study populationSchool-aged adolescentsAdults aged ≥55 yearsHospital patients
Sample/data sizen = 215n = 120Aggregated OPD/IPD records
Age10–18 years≥55 yearsAge-stratified
Study areaBangkokBangkokBangkok and neighboring provinces
Study periodNot clearly specified in sourceJan–Feb 2025Jan–Feb 2025
PM2.5 assessmentExposure/behavior surveyGISTDA monitoringPCD monitoring stations
Respiratory outcomes✓✓✓*
Cardiovascular outcomes—✓✓*
Mask use✓✓—
Outdoor exposure✓✓—
Healthcare utilizationMedical visits—OPD and IPD
Main analytical roleSymptoms and behaviorExposure–symptom relationshipHealthcare burden
Figure 1. Study design and analytical framework. Integrated analysis of PM2.5 impacts on health across age groups and healthcare utilization in Thailand

PM2.5 exposure assessment

Exposure assessment differed across the component studies. For the older-adult study, PM2.5 concentrations were obtained from the Geo-Informatics and Space Technology Development Agency (GISTDA) real-time monitoring system. Daily exposure was estimated according to participants' residential location and time spent outdoors. PM2.5 exposure was categorized into six concentration ranges:

Table 4.

Exposure categoryPM2.5 concentration
10–50 µg/m3
251–75 µg/m3
376–100 µg/m3
4101–125 µg/m3
5126–150 µg/m3
6>151 µg/m3

For the healthcare-utilization analysis, PM2.5 measurements were obtained from Thailand's Pollution Control Department monitoring stations. Hourly observations were aggregated to weekly mean concentrations to correspond with hospital utilization records. Temperature and humidity were incorporated as control variables in the original healthcare model. Because exposure metrics were not identical across all component datasets, PM2.5 measurements were not directly pooled into a single exposure variable.

Health outcome assessment

The principal health outcomes of the present integrated analysis were respiratory outcomes. For adolescents, the analysis focused on reported respiratory symptoms and severe respiratory symptom burden, together with relevant awareness and protective behaviors.

For adults aged 55 years and older, respiratory outcomes included shortness of breath, persistent cough, wheezing, chest tightness, and eye irritation. Cardiovascular and systemic observations recorded in the original study, including elevated blood pressure, palpitations, dizziness, and fatigue, were retained only as secondary exploratory observations and were not treated as primary endpoints of the integrated analysis. For the healthcare dataset, the principal outcomes were the numbers of outpatient visits and inpatient admissions during the corresponding observation periods.

Protective behaviors and outdoor exposure

Protective behavior was evaluated primarily through mask use and outdoor exposure.In the older-adult study, regular users of N95 or equivalent protective masks were compared with individuals who did not consistently use protective masks. Outdoor exposure was classified as low when participants spent <2 hours/day outdoors and high when they spent >4 hours/day outdoors.

These variables were considered potential effect modifiers because they could alter the relationship between ambient PM2.5 concentration and individual health outcomes.

Healthcare utilization dataset

Outpatient and inpatient utilization were evaluated as system-level indicators of healthcare demand. The previously analyzed healthcare dataset examined temporal relationships between ambient fine-particulate-matter concentration and aggregated outpatient and inpatient utilization.

The supplementary raw healthcare dataset was analyzed separately by observation period and age category. The available age groups were 0–10, 11–20, 51–60, and >60 years. Across the available records, there were 6,687 outpatient visits and 1,045 numerically recorded inpatient admissions.

Cells represented by a dash in the original dataset were treated as not reported/missing and were not automatically converted to zero.

Because the observation intervals were not of equal duration, raw interval counts were not interpreted as directly comparable rates. In particular, the interval from 22–31 January contained 10 days, whereas most other intervals contained seven days. Where temporal comparisons were required, utilization was therefore expressed relative to the number of observation days or interpreted with the differing interval lengths explicitly acknowledged.

Statistical analysis

Descriptive statistics were used to summarize participant characteristics, respiratory outcomes, protective behaviors, exposure categories, and healthcare utilization. Continuous variables were summarized using means and standard deviations where appropriate, while categorical variables were summarized using frequencies and percentages.

Within the older-adult dataset, associations between ambient fine-particulate-matter concentration and symptom prevalence were evaluated using the statistical procedures reported in the original epidemiological analysis. Pearson correlation was used to characterize linear relationships, while group comparisons and regression analyses were applied where appropriate.

For healthcare utilization, associations between particulate-matter concentration and outpatient and inpatient demand were evaluated using correlation and ordinary least-squares regression in the original healthcare analysis. The reported associations included r = 0.758 for outpatient utilization and r = 0.691 for inpatient utilization.

Predictive modeling results from the healthcare study were considered exploratory rather than confirmatory because out-of-sample performance was limited. In particular, the reported test-set coefficients of determination were negative for both outpatient and inpatient prediction. Accordingly, predictive estimates were not used as primary evidence for the conclusions of the present study.

A two-sided p < 0.05 was considered statistically significant where inferential statistical testing was applicable. Most importantly, no meta-analysis, participant-level data pooling, or statistical matching across the three component datasets was performed. Cross-dataset integration was descriptive and interpretive.

Ethical considerations

The component studies followed their respective ethical and confidentiality procedures. The healthcare-utilization study used anonymized and aggregated hospital records, with no personally identifiable information included in the analysis.

For the new integrated manuscript, the ethical statement should additionally specify whether the secondary analysis of the raw dataset requires separate approval or exemption under the relevant institutional ethics framework.

Results

Integrated overview of the study populations

The integrated analysis demonstrated complementary patterns of fine-particulate-matter-associated health burden across the component datasets. Respiratory symptoms were observed among adolescents and older adults, while the healthcare dataset demonstrated variation in outpatient and inpatient utilization during the study period. Because the component datasets differed in population, exposure assessment, and outcome measurement, all results were interpreted within their respective datasets rather than as outcomes from a single combined cohort.

PM2.5-related health effects among adolescents

The adolescent component included 215 participants aged 10–18 years. Respiratory symptoms represented the primary health outcome in this population. Overall, 27.9% of participants reported severe respiratory symptoms, while 33.5% demonstrated low awareness of fine particulate matter.

The findings indicate that respiratory health and awareness of air pollution are relevant concerns among adolescents. However, the adolescent dataset did not contain exposure measurements directly comparable with those used in the older-adult dataset. Therefore, no individual-level dose-response relationship was estimated by combining adolescent and older-adult observations.

Protective behaviors, including mask use and modification of outdoor activity, were evaluated descriptively where available. These behavioral observations were not combined statistically with those from the older-adult population.

Respiratory and cardiovascular effects among older adults

The older-adult component included 120 participants aged ≥55 years in Bangkok during January–February 2025. Increasing fine-particulate-matter concentrations were associated with increasing respiratory symptom prevalence, with an overall correlation of approximately r = 0.87 (p < 0.01).

Shortness of breath was reported by 85 participants (70.8%), persistent cough by 72 (60.0%), chest tightness by 65 (54.2%), wheezing by 48 (40.0%), and eye irritation by 40 (33.3%).

These findings demonstrate a strong association between ambient particulate-matter concentration and respiratory symptom burden within this older-adult dataset. Because the study was observational, the association should not be interpreted as proof of an individual causal effect.

Protective effect of mask use and the role of outdoor exposure

Differences in respiratory symptom prevalence were observed according to protective behavior and outdoor exposure among older participants.

Regular mask use was associated with approximately 25–35% lower respiratory symptom prevalence. In contrast, participants with high outdoor exposure experienced nearly twice the symptom rate of those with lower outdoor exposure.

These findings indicate that behavioral factors may modify effective exposure. However, mask use and outdoor activity were not randomly assigned; therefore, these results represent observational associations rather than causal estimates of protection.

Cardiovascular and systemic observations recorded in the source study were considered secondary exploratory findings and were not included as primary outcomes in the integrated analysis.

PM2.5 and healthcare utilization

The healthcare-utilization component covered Bangkok and neighboring provinces during January–February 2025. The mean fine-particulate-matter concentration reported during the study period was 45.7 µg/m3 (SD = 12.3), with concentrations exceeding 70 µg/m3 during high-pollution periods.

Fine-particulate-matter concentration was positively correlated with both outpatient and inpatient utilization. The reported correlation was r = 0.758 (p < 0.05) for outpatient utilization and r = 0.691 (p < 0.05) for inpatient utilization.

Regression analysis indicated that each 10 µg/m3 increase in particulate-matter concentration was associated with approximately 258.1 additional outpatient visits and 13.8 additional inpatient admissions per week.

These estimates describe associations at the aggregated healthcare-system level and should not be interpreted as individual-level risks.

Analysis of the newly available healthcare dataset

The raw healthcare dataset covering 1 January–21 February 2025 provided additional temporal and age-stratified information. Across records with numerical values, there were 6,687 outpatient visits and 1,045 inpatient admissions. Age-specific utilization showed a strong gradient:

Table 2. Age-Specific Healthcare Utilization During January–February 2025

Age groupOPD visits% of OPDIPD admissions*% of recorded IPD
0–10 years4106.1%——
11–20 years2543.8%898.5%
51–60 years2,10331.4%30629.3%
>60 years3,92058.6%65062.2%
Total6,687100%1,045100%

*Dash-coded IPD observations were treated as not reported rather than automatically interpreted as zero.

The >60-year group alone accounted for 58.6% of recorded OPD visits and 62.2% of recorded IPD admissions. When the two older categories were combined, participants aged >50 years represented approximately 90.1% of OPD utilization and 91.5% of recorded IPD utilization within this dataset.

The highest observed outpatient utilization occurred during 22–31 January 2025, when 1,365 OPD visits were recorded. The same period included 203 recorded inpatient admissions. This temporal concentration provides an important opportunity for direct comparison with PM2.5 concentrations during the corresponding period.

Figure 2. PM2.5 concentration and OPD/IPD healthcare utilization in Bangkok and surrounding provinces, 1 January – 21 February 2025. Note: Healthcare utilization was aggregated across age groups and clinical departments (general medicine and ear, nose, and throat) for each time period. PM2.5 concentrations were obtained from ground monitoring stations in Bangkok and surrounding provinces and are presented as weekly mean values. The highest healthcare utilization coincided with the peak PM2.5 level during 22–31 January 2025.

Integrated age-specific pattern

When the three evidence streams were considered together, the health burden followed an age-related continuum. Adolescents primarily demonstrated respiratory symptoms accompanied by variation in awareness and protective behavior. Adults aged ≥55 years demonstrated both respiratory and cardiovascular manifestations, with stronger symptom burden during higher PM2.5 exposure. Healthcare utilization data further showed that older populations accounted for the largest share of outpatient and, particularly, inpatient demand.

The integrated findings can therefore be summarized as:

PM2.5 exposure → respiratory effects in younger populations → respiratory and cardiovascular effects in older adults → increased healthcare utilization, particularly among older age groups.

However, the high proportion of healthcare utilization among older adults should not be interpreted as proof that PM2.5 caused the age difference, because the available hospital dataset does not provide the underlying age-specific population denominators, baseline healthcare utilization rates, or complete adjustment for comorbidities and other time-varying factors.

Table 3. Integrated Summary of PM2.5-Related Health Outcomes Across Age Groups

OutcomeAdolescents 10–18 yOlder adults ≥55 yHealthcare burden
Severe respiratory symptoms27.9%——
Shortness of breath—70.8%—
Persistent cough—60.0%—
Chest tightness—54.2%—
Elevated blood pressure—41.7%—
Palpitations—31.7%—
PM2.5–health association—r = 0.87, p < 0.01OPD: r = 0.758; IPD: r = 0.691
Mask-related reductionProtective behavior assessed25–35% lower symptom prevalence—
High outdoor exposureAssessedNearly 2× symptom rate—
Effect per +10 µg/m3 PM2.5——+258.1 OPD; +13.8 IPD

Key quantitative findings

The most consistent quantitative signals across the datasets were a strong PM2.5–symptom correlation among adults aged ≥55 years (r = 0.87), a 25–35% lower symptom prevalence associated with regular mask use, nearly doubled symptom rates with high outdoor exposure, an estimated +258.1 OPD visits and +13.8 IPD admissions per 10 µg/m3 increase in PM2.5, and a concentration of recorded healthcare utilization among adults aged >50 years.

Together, these results support a multi-level relationship between ambient PM2.5 exposure, individual health effects, behavioral modification of exposure, age-related vulnerability, and healthcare demand.

Discussion

The present study integrated complementary evidence from adolescents, older adults, and healthcare-utilization records to examine the respiratory health burden associated with fine particulate matter in Bangkok and surrounding areas. The principal findings were that respiratory symptoms were observed in both younger and older populations, higher particulate-matter concentrations were associated with greater respiratory symptom burden among older adults, and particulate-matter concentrations were positively associated with outpatient and inpatient healthcare utilization. Importantly, these findings were derived from distinct datasets and should be interpreted as convergent observational evidence rather than as a single individual-level causal pathway.

Respiratory health across the studied populations

Respiratory health emerged as the most consistent outcome across the individual-level datasets. Among adolescents, 27.9% reported severe respiratory symptoms. Among adults aged 55 years and older, respiratory complaints were common, particularly shortness of breath (70.8%), persistent cough (60.0%), chest tightness (54.2%), and wheezing (40.0%). In the older-adult dataset, particulate-matter concentration was strongly correlated with overall symptom prevalence (r ≈ 0.87, p < 0.01).

These findings suggest that respiratory effects associated with air pollution are relevant at different stages of life, although the observed percentages should not be directly compared as estimates of relative susceptibility. The adolescent and older-adult studies differed in participant selection, exposure assessment, outcome definitions, and study procedures. The present analysis therefore does not conclude that one age group was more susceptible than another.

The findings are nevertheless consistent with the broader biological plausibility of respiratory effects from fine particulate matter. Small particles can penetrate deeply into the respiratory tract, where exposure may contribute to airway irritation and inflammatory responses. The present data do not directly measure these biological mechanisms, however, and mechanistic interpretations should therefore be regarded as contextual explanations rather than findings of this study.

Importance of protective behavior and outdoor exposure

Behavioral factors may influence the relationship between ambient pollution and actual personal exposure. Among the older participants, regular mask use was associated with approximately 25–35% lower respiratory symptom prevalence, while participants with high outdoor exposure experienced nearly twice the symptom rate of those with lower outdoor exposure.

These findings have practical implications because exposure-related behaviors are potentially modifiable. During periods of elevated particulate-matter concentration, reducing unnecessary outdoor activity and using appropriate respiratory protection may contribute to lower effective exposure.

However, these results should not be interpreted as randomized evidence of effectiveness. Individuals who regularly used masks may also have differed in health awareness, outdoor activity, underlying health status, or other protective behaviors. Similarly, time spent outdoors may correlate with occupation, physical activity, commuting patterns, and socioeconomic circumstances. Residual confounding therefore remains possible.

The adolescent findings further highlight the importance of awareness. Approximately 33.5% of adolescents were classified as having low awareness of fine-particulate-matter-related health risks. This suggests that environmental-health interventions in schools may benefit from combining air-quality information with practical guidance on how students should respond during high-pollution periods.

Fine particulate matter and healthcare demand

An important aspect of this study was the inclusion of healthcare utilization as a system-level outcome. The healthcare analysis reported a mean particulate-matter concentration of 45.7 ± 12.3 µg/m3 during January–February 2025, with concentrations exceeding 70 µg/m3 during high-pollution periods. Particulate-matter concentration was positively correlated with outpatient utilization (r = 0.758) and inpatient utilization (r = 0.691).

Regression analysis further indicated that each 10 µg/m3 increase in particulate-matter concentration was associated with approximately 258.1 additional outpatient visits and 13.8 additional inpatient admissions per week.

These results suggest that periods of increased air pollution may coincide with increased demand for healthcare services. Nevertheless, the analysis was based on aggregated data. It cannot establish that the individuals represented by increased hospital utilization experienced a particular measured exposure or that fine particulate matter was the sole reason for their healthcare encounters.

Hospital utilization is affected by multiple factors, including seasonal respiratory infections, underlying chronic diseases, population size, healthcare accessibility, temperature, humidity, and healthcare-seeking behavior. The observed relationships should therefore be interpreted as population-level associations.

Age distribution of healthcare utilization

The supplementary healthcare dataset provides additional information regarding the age distribution of healthcare use. Adults aged >60 years accounted for 58.6% of recorded outpatient visits and 62.2% of numerically recorded inpatient admissions. When the 51–60 and >60-year groups were considered together, they represented approximately 90% of outpatient visits and more than 90% of recorded inpatient admissions in this dataset.

The predominance of older patients, particularly among inpatient admissions, was directionally consistent with the previously analyzed healthcare dataset, in which individuals aged ≥60 years accounted for 63.2% of inpatient admissions.

However, these percentages should not be interpreted as demonstrating a higher population-level risk among older adults. The available data did not include population denominators for each age category, and underlying chronic disease prevalence and patterns of healthcare use may differ substantially by age. The findings therefore describe healthcare-utilization distribution rather than age-specific incidence.

Interpretation of the temporal pattern

The supplementary healthcare data initially appeared to show the highest utilization during 22–31 January 2025, with 1,365 outpatient visits and 203 inpatient admissions. However, this period contained 10 observation days, whereas most other intervals contained seven days. Direct comparison of raw counts would therefore be misleading.

After normalization for interval duration, outpatient utilization was highest during 15–21 January (141.0 visits/day), while inpatient utilization was highest during 15–21 February (24.1 admissions/day). This demonstrates the importance of accounting for unequal observation periods when interpreting temporal healthcare patterns.

Furthermore, the currently available source information provides an overall particulate-matter mean and identifies high-pollution periods but does not provide verified particulate-matter concentrations corresponding exactly to each of the seven healthcare intervals. Consequently, the present analysis does not claim that a specific healthcare-utilization peak coincided with a specific particulate-matter concentration.

Future analyses using daily exposure and daily healthcare data would allow more rigorous evaluation of same-day and lagged relationships between pollution and healthcare utilization.

Cardiovascular findings as secondary observations

The older-adult source study also recorded cardiovascular and systemic outcomes, including elevated blood pressure, palpitations, dizziness, and fatigue. In the revised integrated analysis, these findings were retained as secondary contextual observations rather than primary outcomes.

This approach was adopted because the available datasets provide stronger and more consistent evidence for respiratory outcomes. Moreover, cardiovascular responses to particulate matter involve complex biological pathways and may be affected by underlying cardiovascular disease, medication use, age, and other clinical characteristics that could not be comprehensively controlled in the integrated dataset.

Accordingly, the present study does not attempt to establish an independent causal relationship between particulate-matter exposure and cardiovascular disease. Future studies specifically designed around cardiovascular endpoints would be required to address this question more rigorously.

Public health and healthcare implications

The integrated findings have implications at both individual and healthcare-system levels. For adolescents, improving understanding of air-quality information and appropriate protective behavior may be particularly relevant. Schools may use environmental monitoring information to guide outdoor activities during periods of elevated pollution.

For older adults, preventive communication may need to emphasize both exposure reduction and early recognition of worsening respiratory symptoms. Individuals with pre-existing respiratory disease may require additional attention during severe pollution episodes.

At the healthcare-system level, environmental monitoring may complement routine healthcare surveillance. Periods of elevated particulate matter could be considered alongside seasonal disease patterns when planning outpatient capacity, respiratory services, staffing, and other resources.

However, the predictive models reported in the original healthcare study should not yet be regarded as validated forecasting tools. Although significant associations were observed, out-of-sample performance was limited, with test-set R2 values of −1.88 for outpatient and −0.74 for inpatient predictions. Negative test-set R2 values indicate poor predictive generalization. The regression findings are therefore more appropriately interpreted as evidence of association than as evidence of reliable future forecasting.

Strengths of the study

A principal strength of this study is its integration of evidence at different levels of observation. Rather than examining respiratory symptoms or hospital utilization in isolation, the study considers adolescent health, older-adult respiratory outcomes, protective behaviors, environmental exposure, and healthcare utilization within a common conceptual framework.

A second strength is the explicit separation of the component datasets. Individual records were not artificially merged, and healthcare counts were not attributed to participants from the adolescent or older-adult studies. This approach reduces the risk of ecological interpretation being presented incorrectly as an individual-level association.

The additional age-stratified healthcare dataset also provides useful descriptive information regarding which age groups accounted for recorded healthcare utilization during the observation period.

Limitations

Several limitations should be considered. First, the component datasets were collected using different study designs, populations, exposure assessments, and outcome definitions. Consequently, direct statistical comparison across datasets was not appropriate.

Second, respiratory symptoms and some exposure-related behaviors were self-reported, introducing potential recall and reporting bias. Ambient monitoring measurements may also differ from actual personal exposure because participants spend different amounts of time indoors, outdoors, in transit, and in environments with different filtration conditions.

Third, the study period was relatively short, particularly for the older-adult and healthcare components. Seasonal patterns observed during January–February cannot necessarily be generalized to other periods of the year.

Fourth, residual confounding remains possible. Respiratory infections, chronic diseases, socioeconomic characteristics, indoor air pollution, smoking or secondhand-smoke exposure, healthcare access, meteorological conditions, and other environmental factors could influence the observed outcomes.

Fifth, the healthcare data were aggregated and did not contain population denominators sufficient to calculate age-specific incidence rates. Therefore, a large proportion of hospital utilization among older adults should not be interpreted as evidence that particulate matter caused a higher individual risk in that group.

Sixth, the supplementary healthcare dataset may overlap with records included in the previously analyzed hospital dataset. The two datasets were therefore not summed or treated as independent samples.

Finally, the geographical coverage was concentrated in Bangkok, Nonthaburi, and surrounding provinces. Although the findings contribute evidence relevant to fine-particulate-matter-related health burden in Thailand, they should not be interpreted as nationally representative estimates for the entire Thai population.

Overall interpretation

Taken together, the component datasets provide complementary evidence that fine-particulate-matter exposure is associated with respiratory health burden among adolescents and older adults and with healthcare utilization in Bangkok and surrounding areas.

The integrated evidence is most appropriately summarized as:

Fine particulate matter exposure → respiratory health burden and exposure-related behavioral differences → population-level healthcare demand

This framework does not imply that the same individuals were followed through each stage. Instead, it illustrates how independently collected evidence can describe different dimensions of a shared environmental health problem.

The findings support continued development of age-responsive air-pollution prevention, improved public awareness, appropriate exposure-reduction strategies, and integration of environmental information into healthcare preparedness.

Prospective studies using synchronized daily exposure and health data, individual-level exposure measurements, clearly defined population denominators, and appropriate control of confounding are needed to strengthen causal inference and determine how pollution episodes translate into healthcare demand.

Conclusion

This integrated analysis provides complementary evidence that fine particulate matter exposure is associated with respiratory health burden and healthcare utilization in Bangkok and surrounding areas. Respiratory symptoms were observed among both adolescents and older adults, while the older-adult dataset demonstrated a strong positive association between particulate-matter concentration and respiratory symptom prevalence. Protective behaviors were also relevant, with regular mask use associated with lower symptom prevalence and greater outdoor exposure associated with a higher symptom burden.

At the healthcare-system level, increasing particulate-matter concentrations were positively associated with both outpatient and inpatient utilization. The healthcare analysis reported correlations of r = 0.758 for outpatient visits and r = 0.691 for inpatient admissions, indicating that periods of higher particulate-matter concentrations coincided with greater healthcare demand. The supplementary healthcare dataset further showed that adults aged over 60 years accounted for the largest proportion of recorded outpatient and inpatient utilization. These age-stratified findings describe the distribution of healthcare use and should not be interpreted as population-based estimates of individual risk.

Overall, the findings support an age-responsive approach to air-pollution prevention. For adolescents, improved environmental-health awareness and appropriate modification of outdoor activities may help reduce exposure. For older adults, exposure reduction and timely recognition of respiratory symptoms may be particularly important. At the healthcare-system level, incorporating air-quality information into preparedness planning may assist services in responding to periods of increased respiratory healthcare demand.

The findings should nevertheless be interpreted within the limitations of an integrated observational analysis. The component datasets were collected independently, participants were not linked across datasets, and the geographical coverage was concentrated in Bangkok, Nonthaburi, and surrounding areas. The present study therefore provides convergent observational evidence rather than proof of a single causal pathway or nationally representative estimates for Thailand.

Future research should use prospective designs with synchronized daily air-pollution and healthcare data, individual-level exposure assessment, clearly defined population denominators, and adjustment for meteorological, clinical, behavioral, and socioeconomic confounders. Such studies would strengthen understanding of how fine-particulate-matter exposure translates into respiratory morbidity and healthcare demand across different population groups.

References

  1. Atkinson, R. W., Kang, S., Anderson, H. R., Mills, I. C., & Walton, H. A. (2014). Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: A systematic review and meta-analysis. Thorax, 69(7), 660–665. https://doi.org/10.1136/thoraxjnl-2013-204492
  2. Brook, R. D., Rajagopalan, S., Pope, C. A., III, Brook, J. R., Bhatnagar, A., Diez-Roux, A. V., Holguin, F., Hong, Y., Luepker, R. V., Mittleman, M. A., Peters, A., Siscovick, D., Smith, S. C., Jr., Whitsel, L., & Kaufman, J. D. (2010). Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation, 121(21), 2331–2378. https://doi.org/10.1161/CIR.0b013e3181dbece1
  3. Brauer, M., Southerland, V. A., Mohegh, A., Hammer, M. S., van Donkelaar, A., Martin, R. V., Apte, J. S., & Anenberg, S. C. (2022). Global urban temporal trends in fine particulate matter (PM2.5) and attributable health burdens: Estimates from global datasets. The Lancet Planetary Health. https://doi.org/10.1016/S2542-5196(21)00350-8
  4. Chen, X., Zhao, J., Liu, M., & Li, Y. (2020). The effects of PM2.5 exposure on lung function and respiratory symptoms in children: A systematic review and meta-analysis. Environmental Research, 190, 110032. https://doi.org/10.1016/j.envres.2020.110032
  5. Gauderman, W. J., Urman, R., Avol, E., Berhane, K., McConnell, R., Rappaport, E. B., Chang, R., Lurmann, F., & Gilliland, F. (2015). Association of improved air quality with lung development in children. The New England Journal of Medicine, 372(10), 905–913. https://doi.org/10.1056/NEJMoa1414123
  6. GBD 2019 Risk Factors Collaborators. (2020). Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1223–1249. https://doi.org/10.1016/S0140-6736(20)30752-2
  7. Gu, K., Zhou, M., Luo, W., Liu, Y., Dou, P., Huang, C., & Di, Q. (2023). Long-term exposure to fine particulate matter and cardiovascular disease: The mitigation role of environmental concerns. Science of the Total Environment, 875, 162656. https://doi.org/10.1016/j.scitotenv.2023.162656
  8. Kaufman, J. D., Elkind, M. S. V., Bhatnagar, A., Koehler, K., Balmes, J. R., Sidney, S., Burroughs Peña, M. S., Dockery, D. W., Hou, L., Brook, R. D., Laden, F., Rajagopalan, S., Kendrick, K. B., & Turner, J. R. (2020). Guidance to reduce the cardiovascular burden of ambient air pollutants: A policy statement from the American Heart Association. Circulation, 142(23), e432–e447. https://doi.org/10.1161/CIR.0000000000000930
  9. Kiatsoongsong, P., & Ekvitayavetchanukul, P. (2025). Associations between daily PM2.5 exposure and respiratory symptoms in Thai adolescents: Evidence from Nonthaburi Province. American Journal of Environment and Climate, 4(3), 59–68. https://doi.org/10.54536/ajec.v4i3.5093
  10. Lee, J. Y., & Kim, H. (2018). Ambient air pollution-induced health risk for children worldwide. The Lancet Planetary Health. https://doi.org/10.1016/S2542-5196(18)30149-9
  11. Li, K., Bao, Y., Gao, J., Chen, B., Xia, Y., Zhao, Y., Chen, H., Wang, J., & Zhang, H. (2025). Chemical constituents of PM2.5 and their association with childhood asthma and lung function: A systematic review and meta-analysis. European Journal of Pediatrics, 184(7), 395. https://doi.org/10.1007/s00431-025-06214-5
  12. Liang, F., Liu, F., Huang, K., Yang, X., Li, J., Xiao, Q., Chen, J., Liu, X., Cao, J., Shen, C., Yu, L., Lu, F., Wu, X., Wu, X., Li, Y., Hu, D., Huang, J., Liu, Y., Lu, X., & Gu, D. (2020). Long-term exposure to fine particulate matter and cardiovascular disease in China. Journal of the American College of Cardiology, 75(7), 707–717. https://doi.org/10.1016/j.jacc.2019.12.031
  13. Liu, C., Chen, R., Sera, F., Vicedo-Cabrera, A. M., Guo, Y., Tong, S., Coelho, M. S. Z. S., Saldiva, P. H. N., Lavigne, E., Matus, P., et al. (2019). Ambient particulate air pollution and daily mortality in 652 cities. The New England Journal of Medicine, 381(8), 705–715. https://doi.org/10.1056/NEJMoa1817364
  14. Liu, C., Chan, K. H., et al. (2022). Long-term exposure to ambient fine particulate matter and incidence of major cardiovascular diseases: A prospective study of 0.5 million adults in China. Environmental Science & Technology, 56(18), 13200–13211. https://doi.org/10.1021/acs.est.2c03084
  15. Liu, Q., Xu, C., Ji, G., Shao, W., Zhang, C., Gu, A., & Zhao, P. (2017). Effect of exposure to ambient PM2.5 pollution on the risk of respiratory tract diseases: A meta-analysis of cohort studies. Journal of Biomedical Research. https://doi.org/10.7555/JBR.31.20160071
  16. Ni, R., Su, H., Burnett, R. T., Guo, Y., & Cheng, Y. (2024). Long-term exposure to PM2.5 has significant adverse effects on childhood and adult asthma: A global meta-analysis and health impact assessment. One Earth. https://doi.org/10.1016/j.oneear.2024.04.087
  17. Pongthong, S., Chantara, S., & Wiriya, W. (2022). Sources and seasonal variations of PM2.5-bound heavy metals and their health risks in Bangkok. Atmospheric Pollution Research, 13(2), 101333. https://doi.org/10.1016/j.apr.2021.101333
  18. Rajagopalan, S., Al-Kindi, S. G., & Brook, R. D. (2018). Air pollution and cardiovascular disease: JACC state-of-the-art review. Journal of the American College of Cardiology, 72(17), 2054–2070. https://doi.org/10.1016/j.jacc.2018.07.099
  19. Rückerl, R., Schneider, A., Breitner, S., Cyrys, J., & Peters, A. (2011). Health effects of particulate air pollution: A review of epidemiological evidence. Inhalation Toxicology, 23(10), 555–592. https://doi.org/10.3109/08958378.2011.593587
  20. Somjit, P., Dechpong, P., Limpanich, P., Tuanthet, K., Srisongkram, N., Nakornrum, C., & Ekvitayavetchanukul, P. (2025). Daily PM2.5 exposure and its association with respiratory symptoms among high school students in Nonthaburi Province: A cross-sectional study. East African Scholars Journal of Medical Sciences, 8(6), 183–193. https://doi.org/10.36349/easms.2025.v08i06.001
  21. Takebayashi, T., Taguri, M., Odajima, H., & Morita, Y. (2022). Exposure to PM2.5 and lung function growth in pre- and early-adolescent schoolchildren: A longitudinal study involving repeated lung function measurements. Annals of the American Thoracic Society. https://doi.org/10.1513/AnnalsATS.202104-511OC
  22. Zhang, Y., Guo, Z., Zhang, W., Li, Q., Zhao, Y., Wang, Z., & Luo, Z. (2023). Effect of acute PM2.5 exposure on lung function in children: A systematic review and meta-analysis. Journal of Asthma and Allergy, 16, 529–540. https://doi.org/10.2147/JAA.S405929
  23. Zhang, Y., et al. (2022). The relationship between particulate matter and lung function of children: A systematic review and meta-analysis. Environmental Pollution, 309, 119735. https://doi.org/10.1016/j.envpol.2022.119735
  24. Nhung, N. T. T., Amini, H., Schindler, C., Kutlar Joss, M., Dien, T. M., Probst-Hensch, N., Perez, L., & Künzli, N. (2017). Short-term association between ambient air pollution and pneumonia in children: A systematic review and meta-analysis of time-series and case-crossover studies. Environmental Pollution, 230, 1000–1008. https://doi.org/10.1016/j.envpol.2017.07.063
  25. Yee, J., Cho, Y. A., Yoo, H. J., Yun, H., & Gwak, H. S. (2021). Short-term exposure to air pollution and hospital admission for pneumonia: A systematic review and meta-analysis. Environmental Health, 20, 6. https://doi.org/10.1186/s12940-020-00687-7
  26. Wu, T., Fang, Y., Zhou, Y., & Li, J. (2022). Protective effects of personal air filtration on reducing PM2.5 exposure and associated health risks in school children. Environmental Science & Technology, 56(5), 3241–3250. https://doi.org/10.1021/acs.est.1c08079
  27. Chamchalam, I., Thaveevuttivaranon, P., Suphasit, K. S., Jitrach, J., Morrakot, S., Korchalermsonthi, N., & Ekvitayavetchanukul, P. (2025). The impact of PM2.5 on the health of primary school students aged 10–13 in Bangkok. International Journal of Research and Innovation in Social Science, 9(5), 5328–5339. https://doi.org/10.47772/IJRISS.2025.905000411
  28. Kittiwattanokhun, T., Punyapru, C., Punyapru, P., Jiracheeveewong, A., Wongsamut, T., Saenjaiwut, W., & Ekvitayavetchanukul, P. (2025). The hidden dangers of PM2.5: Air pollution and its health risks for high school students in Bangkok. Journal of Neonatal Surgery, 14(26S), 441–450.
  29. Mathasuriyapong, P., Korchalermsonthi, N., Ekvitayavetchanukul, P., & Ekvitayavetchanukul, P. (2025). Modeling the health burden of PM2.5: Forecasting hospital admissions and medical demand in Bangkok and neighboring regions. Journal of Posthumanism, 5(6), 862–873. https://doi.org/10.63332/joph.v5i6.2155
  30. Jansomboon, N., Klongkan, A., Prateep, L., Prateep, S., Pattarmakarnon, P., & Ekvitayavetchanukul, P. (2025). Health impacts of PM2.5 exposure on older adults (55+) in Bangkok: An epidemiological study. International Journal of Preventive Medicine and Health, 5(6). https://doi.org/10.54105/ijpmh.E1108.05060925
  31. Suksai, K., Thitipobromyen, S., Bunkham, C., Pattanapuapa, N., & Ekvitayavetchanukul, P. (2025). Blue Carbon Learning Center design along the Chao Phraya River: A case study of wetland zones in Nonthaburi Province. RA Journal of Applied Research, 11(8). https://doi.org/10.47191/rajar/v11i8.04
  32. World Health Organization. (2021). WHO global air quality guidelines: Particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. World Health Organization. WHO Global Air Quality Guidelines

Article information

Authors

How to cite

Ekvitayavetchanukul, P., Rirattanapong, N., et al., 2026. Health Impacts of PM2.5 in Adolescents and Older Adults in Bangkok and Surrounding Areas: An Integrated Analysis of Respiratory Outcomes and Healthcare Utilization. Medical Research Archives, [online] 14(10). https://doi.org/10.18103/mra.2026.0670

Record

Journal
Medical Research Archives
Section
Research Articles
Published
31 October 2026
ISSN
2375-1924
Downloads
65

Copyright and licence

Published by the European Society of Medicine under a Creative Commons Attribution 4.0 International licence (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original authors and source are credited.